Differences in Protein Expression and Gene Amplification of Cyclins Between Colon and Rectal Adenocarcinomas

Overview

Journal Gastroenterol Res Pract

Publisher Wiley

Specialty Gastroenterology

Date 2009 Dec 24

PMID 20029639

Citations 10

Authors

Rolf Aamodt

Kristin Jonsdottir

Solveig Norheim Andersen

Johan Bondi

Geir Bukholm

Ida R K Bukholm

Affiliations

Soon will be listed here.

Abstract

Adenocarcinomas of rectum and colon may be different with regard to the cellular biological basis for cancer development. A material of 246 rectal cancers removed surgically at Akershus University Hospital in the years 1992-2000 was investigated and was compared to a material of 219 colon cancers operated on at Akershus University Hospital during the years 1988, 1990 and 1997-2000. There were highly significant differences between the rectal and the colon cancers in the protein expression of cyclin D1, cyclin D3, cyclin E, nuclear beta-catenin, and c-Myc and in gene amplification of cyclin A2, cyclin B1, cyclin D1, and cyclin E. Gene amplification and protein expression in the rectal cancers correlated significantly for the cyclins B1, D3, and E. A statistically significant relation was observed between overexpression of cyclin A2 and local relapse of rectal carcinomas, as higher expression of cyclin A2 was associated with lower local recurrence rate.

Citing Articles

Plasma protein expression differs between colorectal cancer patients depending on primary tumor location.

Holm M, Joenvaara S, Saraswat M, Tohmola T, Ristimaki A, Renkonen R Cancer Med. 2020; 9(14):5221-5234.

PMID: 32452655 PMC: 7367633. DOI: 10.1002/cam4.3178.

RIPK1 polymorphisms alter the susceptibility to cervical Cancer among the Uyghur population in China.

Tuoheti Z, Han L, Husaiyin S, Liu X, Ma C, Niyazi M BMC Cancer. 2020; 20(1):299.

PMID: 32272907 PMC: 7146988. DOI: 10.1186/s12885-020-06779-4.

Are Colon and Rectal Cancer Two Different Tumor Entities? A Proposal to Abandon the Term Colorectal Cancer.

Paschke S, Jafarov S, Staib L, Kreuser E, Maulbecker-Armstrong C, Roitman M Int J Mol Sci. 2018; 19(9).

PMID: 30200215 PMC: 6165083. DOI: 10.3390/ijms19092577.

Adjuvant chemotherapy.

Glimelius B EJC Suppl. 2015; 11(2):72-9.

PMID: 26217115 PMC: 4041477. DOI: 10.1016/j.ejcsup.2013.07.034.

Expression profiling of rectal tumors defines response to neoadjuvant treatment related genes.

Palma P, Cano C, Conde-Muino R, Comino A, Bueno P, Ferron J PLoS One. 2014; 9(11):e112189.

PMID: 25380052 PMC: 4224421. DOI: 10.1371/journal.pone.0112189.

References

Thomson P, Hamadah O, Goodson M, Cragg N, Booth C . Predicting recurrence after oral precancer treatment: use of cell cycle analysis. Br J Oral Maxillofac Surg. 2008; 46(5):370-5. DOI: 10.1016/j.bjoms.2008.01.003. View

Poikonen P, Sjostrom J, Amini R, Villman K, Ahlgren J, Blomqvist C . Cyclin A as a marker for prognosis and chemotherapy response in advanced breast cancer. Br J Cancer. 2005; 93(5):515-9. PMC: 2361595. DOI: 10.1038/sj.bjc.6602735. View

Chen H, Yen-Ping Kuo M, Lin K, Lin C, Chiang C . Expression of cyclin A is related to progression of oral squamous cell carcinoma in Taiwan. Oral Oncol. 2003; 39(5):476-82. DOI: 10.1016/s1368-8375(03)00007-1. View

Nakabayashi H, Shimizu K, Hara M . Prognostic significance of cyclin a expression in meningiomas. Appl Immunohistochem Mol Morphol. 2003; 11(1):9-14. DOI: 10.1097/00129039-200303000-00002. View

Korshunov A, Shishkina L, Golanov A . DNA topoisomerase II-alpha and cyclin A immunoexpression in meningiomas and its prognostic significance: an analysis of 263 cases. Arch Pathol Lab Med. 2002; 126(9):1079-86. DOI: 10.5858/2002-126-1079-DTIACA. View

Girard F, Strausfeld U, Fernandez A, Lamb N . Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell. 1991; 67(6):1169-79. DOI: 10.1016/0092-8674(91)90293-8. View

Bahnassy A, Zekri A, El-Houssini S, El-Shehaby A, Mahmoud M, Abdallah S . Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients. BMC Gastroenterol. 2004; 4:22. PMC: 524166. DOI: 10.1186/1471-230X-4-22. View

Dang C . c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol. 1998; 19(1):1-11. PMC: 83860. DOI: 10.1128/MCB.19.1.1. View

Walker D, Maller J . Role for cyclin A in the dependence of mitosis on completion of DNA replication. Nature. 1991; 354(6351):314-7. DOI: 10.1038/354314a0. View

10.

Platzer P, Upender M, Wilson K, Willis J, Lutterbaugh J, Nosrati A . Silence of chromosomal amplifications in colon cancer. Cancer Res. 2002; 62(4):1134-8. View

11.

Bondi J, Bukholm G, Nesland J, Bukholm I . Expression of non-membranous beta-catenin and gamma-catenin, c-Myc and cyclin D1 in relation to patient outcome in human colon adenocarcinomas. APMIS. 2004; 112(1):49-56. DOI: 10.1111/j.1600-0463.2004.apm1120109.x. View

12.

Nakamura N, Yamamoto H, Yao T, Oda Y, Nishiyama K, Imamura M . Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade. Hum Pathol. 2005; 36(7):828-37. DOI: 10.1016/j.humpath.2005.03.012. View

13.

Buckley M, Sweeney K, Hamilton J, Sini R, Manning D, Nicholson R . Expression and amplification of cyclin genes in human breast cancer. Oncogene. 1993; 8(8):2127-33. View

14.

Wolowiec D, Berger F, Ffrench P, Bryon P, Ffrench M . CDK1 and cyclin A expression is linked to cell proliferation and associated with prognosis in non-Hodgkin's lymphomas. Leuk Lymphoma. 1999; 35(1-2):147-57. DOI: 10.3109/10428199909145714. View

15.

Noguchi T, Dobashi Y, Minehara H, Itoman M, Kameya T . Involvement of cyclins in cell proliferation and their clinical implications in soft tissue smooth muscle tumors. Am J Pathol. 2000; 156(6):2135-47. PMC: 1850071. DOI: 10.1016/S0002-9440(10)65084-5. View

16.

Engellau J, Bendahl P, Persson A, Domanski H, Akerman M, Gustafson P . Improved prognostication in soft tissue sarcoma: independent information from vascular invasion, necrosis, growth pattern, and immunostaining using whole-tumor sections and tissue microarrays. Hum Pathol. 2005; 36(9):994-1002. DOI: 10.1016/j.humpath.2005.07.008. View

17.

Prochownik E . c-Myc as a therapeutic target in cancer. Expert Rev Anticancer Ther. 2004; 4(2):289-302. DOI: 10.1586/14737140.4.2.289. View

18.

Fernebro E, Halvarsson B, Baldetorp B, Nilbert M . Predominance of CIN versus MSI in the development of rectal cancer at young age. BMC Cancer. 2002; 2:25. PMC: 130963. DOI: 10.1186/1471-2407-2-25. View

19.

Furihata M, Ohtsuki Y, Sonobe H, Shuin T, Yamamoto A, Terao N . Cyclin A overexpression in carcinoma of the renal pelvis and ureter including dysplasia: immunohistochemical findings in relation to prognosis. Clin Cancer Res. 1997; 3(8):1399-404. View

20.

Nozoe T, Inutsuka S, Honda M, Ezaki T, Korenaga D . Clinicopathologic significance of cyclin A expression in colorectal carcinoma. J Exp Clin Cancer Res. 2004; 23(1):127-33. View